Publications in 2025
Featured Products
-
7-Hydroxy-2',5,8-trimethoxyflavanone
CAS NO.:100079-34-3 Cat. No.:BCN5817 -
2',4'-Dihydroxy-2,3',6'-trimethoxychalcone
CAS NO.:100079-39-8 Cat. No.:BCN1643 -
Chloramultilide B
CAS NO.:1000995-47-0 Cat. No.:BCN6613 -
Chloramultilide C
CAS NO.:1000995-48-1 Cat. No.:BCN6618 -
Chloramultilide D
CAS NO.:1000995-49-2 Cat. No.:BCN7102 -
1,4,5,6-Tetrahydroxy-7-prenylxanthone
CAS NO.:1001424-68-5 Cat. No.:BCN1642 -
Piscidinol A
CAS NO.:100198-09-2 Cat. No.:BCN5818 -
Dihydroresveratrol 3-O-glucoside
CAS NO.:100432-87-9 Cat. No.:BCN5821 -
Gelomulide N
CAS NO.:1005212-02-1 Cat. No.:BCN6641 -
Monomethylsulochrin
CAS NO.:10056-14-1 Cat. No.:BCN7255 -
(-)-Epipinoresinol
CAS NO.:10061-38-8 Cat. No.:BCN3377 -
1-O-Deacetylkhayanolide E
CAS NO.:1007387-95-2 Cat. No.:BCN5823 -
Larixinol
CAS NO.:101046-79-1 Cat. No.:BCN6484 -
Longipedlactone J
CAS NO.:1011762-93-8 Cat. No.:BCN6644 -
Kushenol L
CAS NO.:101236-50-4 Cat. No.:BCN3309 -
Kushenol M
CAS NO.:101236-51-5 Cat. No.:BCN3310 -
Formosanol
CAS NO.:101312-79-2 Cat. No.:BCN5826 -
5''-O-Syringoylkelampayoside A
CAS NO.:1014974-98-1 Cat. No.:BCN4798 -
trans-2,3-Dihydro-3-ethoxyeuparin
CAS NO.:1015698-14-2 Cat. No.:BCN6923 -
Barpisoflavone A
CAS NO.:101691-27-4 Cat. No.:BCN4739 -
Olivil monoacetate
CAS NO.:1016974-78-9 Cat. No.:BCN4738 -
6-O-p-Hydroxybenzoylaucubin
CAS NO.:1016987-87-3 Cat. No.:BCN5831 -
Sanggenofuran B
CAS NO.:1017277-40-5 Cat. No.:BCN7194 -
Desacetylmatricarin
CAS NO.:10180-88-8 Cat. No.:BCN7258 -
Protosappanin A
CAS NO.:102036-28-2 Cat. No.:BCN7259 -
3-O-Methyltirotundin
CAS NO.:1021945-29-8 Cat. No.:BCN5837 -
Negsehisandrin G
CAS NO.:1023744-69-5 Cat. No.:BCN2674 -
Kushenol N
CAS NO.:102490-65-3 Cat. No.:BCN2984 -
Periglaucine A
CAS NO.:1025023-04-4 Cat. No.:BCN5839 -
Periglaucine B
CAS NO.:1025023-05-5 Cat. No.:BCN7053
New Products
-
Mangostanin
CAS NO.:463342-39-4 Cat. No.:BCX2146 -
4-Hydroxy-2-methoxybenzoic acid
CAS NO.:90111-34-5 Cat. No.:BCX2145 -
15-O-Methylgraciliflorin F
CAS NO.:1411994-51-8 Cat. No.:BCX2144 -
Hydrastinine
CAS NO.:5936-29-8 Cat. No.:BCX2143 -
Notoginsenoside E
CAS NO.:193976-50-0 Cat. No.:BCX2142 -
5-Allyl-1-methoxy-2,3-dihydroxybenzene
CAS NO.:4055-72-5 Cat. No.:BCX2141 -
Auranamide
CAS NO.:740813-53-0 Cat. No.:BCX2140 -
Terrestriamide
CAS NO.:157536-49-7 Cat. No.:BCX2139 -
Quercetin-5-O-glucoside-3-O-rutinoside
CAS NO.:1478622-04-6 Cat. No.:BCX2138 -
Praeroside I
CAS NO.:121064-73-1 Cat. No.:BCX2137 -
Cryptostigmin II
CAS NO.:50906-57-5 Cat. No.:BCX2136 -
Davidigenin
CAS NO.:23130-26-9 Cat. No.:BCX2135 -
Pinocembrin 7-O-neohesperidoside
CAS NO.:13241-31-1 Cat. No.:BCX2134 -
Gerardianin A
CAS NO.:137171-31-4 Cat. No.:BCX2133 -
Euphopiloside A
CAS NO.:1610615-04-7 Cat. No.:BCX2132 -
Graciliflorin F
CAS NO.:1413941-67-9 Cat. No.:BCX2131 -
Eugenol 4-O-beta-D-(6'-O-galloyl) glucopyranoside
CAS NO.:152041-15-1 Cat. No.:BCX2130 -
Plumbagic acid
CAS NO.:75640-06-1 Cat. No.:BCX2129 -
Etuycomanol
CAS NO.:84633-28-3 Cat. No.:BCX2128 -
Ellagic acid glucoside
CAS NO.:163774-64-9 Cat. No.:BCX2127 -
Isorhamnetin 3-sambubioside
CAS NO.:142059-76-5 Cat. No.:BCX2126 -
3'-Methoxynyasin
CAS NO.:1685246-20-1 Cat. No.:BCX2125 -
8-C-beta-D-(6-O-galloyl)glucosylnoreugenin
CAS NO.:152041-17-3 Cat. No.:BCX2124 -
Callicapoic acid M1
CAS NO.:2756970-65-5 Cat. No.:BCX2123 -
1,5-Epoxy-3S-hydroxy-1-(3,4-dihydroxy-5-methoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)heptane
CAS NO.:182369-54-6 Cat. No.:BCX2122 -
6,8-Di-C-beta-D-glucopyranosylacacetin
CAS NO.:28234-99-3 Cat. No.:BCX2121 -
Isocarthamidin 7-O-glucuronide
CAS NO.:119600-61-2 Cat. No.:BCX2120 -
7-O-Methylhorminone
CAS NO.:122482-10-4 Cat. No.:BCX2119 -
Isolophanthin B
CAS NO.:1370511-57-1 Cat. No.:BCX2118 -
Fischeroside B
CAS NO.:1307257-08-4 Cat. No.:BCX2117
Browse by Research Area
Innovative tools for life science research
Neuroscience
Neuroscience
Cardiovascular
Cardiovascular
Cell Cycle
Cell Cycle
Apoptosis
Apoptosis
Immunology
Immunology
microbiology and virology
Microbiology and Virology
GPCR/G protein
GPCR/G protein
Epigenetics
Epigenetics
Stem Cells
Stem Cells
Our Expertise
We make all our products from start to finish, so we know every last detail about
each one.
Plus, we test every single product in a variety of applications as standard, refusing
to sell any products without high quality.
Access our expertise and technical support from anywhere in the world, 24 hours
a day – kindly please contact us if you need.
- Data available on request.
- 24 hours technical support.
Our Guarantee
We cover all our products with our hassle-free, full money-back refund – we don’t
think you’ll need to use it, but it’s there just in case.
Our guarantee gives you the confidence to put our products to the test in a risk-free
environment.
Application is not listed on our datasheet will still be covered by our guarantee.
- All your money back, (including shipping costs).
- Cash, credit.
Natural Products and Cancer: Bridging the Gap Between Preclinical Promise and Clinical Reality
The remarkable potential of natural products in oncology has long been recognized by the scientific and medical communities. From paclitaxel to vincristine, plant-derived compounds have played a central role in the development of some of the most successful anticancer agents in modern medicine. Yet, despite decades of promising preclinical research, many natural compounds remain stalled in laboratory studies, never making the critical leap into clinical evaluation. At BioCrick, we believe that the future of cancer therapy lies in the intersection of tradition and innovation. Our extensive catalog of high-quality natural compounds offers a foundation for groundbreaking research, incl ……view more
An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer
Epigenetic Modulation of Colorectal Cancer: The Promising Role of Natural Compounds Colorectal cancer (CRC) continues to pose a significant global health challenge despite advances in therapeutic approaches over recent decades. Emerging evidence highlights the pivotal role of epigenetic mechanisms—including DNA methylation, histone modifications, and non-coding RNAs—in the initiation and progression of CRC. These epigenetic alterations influence key signaling pathways such as Wnt/β-catenin, NF-κB, and PI3K/AKT, which regulate cancer cell proliferation, oxidative stress, inflammation, and apoptosis. Advances in Cancer Epigenetics and ……view more
